TAAR1 and cytomegalovirus infection: Thus, the aim of this study was to evaluate the immunological effects of combined treatment with Tα1 and two PCDs (G2-S16 or G2-S24P) during early HCMV infection in vitro in order to determine if there could be a synergistic effect between both treatments, suggesting their use as a therapeutic alternative for the prophylaxis of HCMV infection.